{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:00:22Z","timestamp":1789189222482,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.cardfail.2014.12.011","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T07:15:21Z","timestamp":1420442121000},"page":"208-216","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic Value of Aldosterone and Cortisol in Patients Hospitalized for Acutely Decompensated Chronic Heart Failure With and Without Mineralocorticoid Receptor Antagonism"],"prefix":"10.1016","volume":"21","author":[{"given":"G\u00fclmisal","family":"G\u00fcder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Deutschbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Berliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NiKolas","family":"Deubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Allolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane E.","family":"Angermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"St\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2014.12.011_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/CS20060275","article-title":"Mineralocorticoid receptor activation and cardiac fibrosis","volume":"112","author":"Young","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cardfail.2014.12.011_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.12.011_bib3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.12.011_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.12.011_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.mce.2011.06.038","article-title":"Aldosterone, mineralocorticoid receptor, and heart failure","volume":"350","author":"Messaoudi","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2014.12.011_bib7","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction","volume":"54","author":"Mihailidou","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2014.12.011_bib8","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure","volume":"115","author":"Guder","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.12.011_bib9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1161\/CIRCHEARTFAILURE.109.868513","article-title":"Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress","volume":"2","author":"Yamaji","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2014.12.011_bib10","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1365-2362.2012.02676.x","article-title":"Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances","volume":"42","author":"Galuppo","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cardfail.2014.12.011_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.111.962969","article-title":"Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study","volume":"5","author":"Angermann","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2014.12.011_bib12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/ehs361","article-title":"Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients","volume":"34","author":"Drechsler","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2014.12.011_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1677\/JOE-07-0134","article-title":"A highly sensitive immunofluorometric assay for the measurement of aldosterone in small sample volumes: validation in mouse serum","volume":"196","author":"Manolopoulou","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1530\/EJE-11-1013","article-title":"Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies","volume":"167","author":"Hannemann","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2014.12.011_bib16","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.12.011_bib17","first-page":"E883","article-title":"The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis","volume":"271","author":"Young","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.CIR.0000135599.33787.CA","article-title":"Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways","volume":"110","author":"Mano","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.12.011_bib19","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.12.011_bib20","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES)","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.12.011_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10741-005-2351-3","article-title":"Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure","volume":"10","author":"Zannad","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cardfail.2014.12.011_bib22","first-page":"31","article-title":"Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling","volume":"20","author":"Healey","year":"2005","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.CIR.0000138973.55605.38","article-title":"Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction","volume":"110","author":"Perrier","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.12.011_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2011.06.100","article-title":"Aldosterone induces electrical remodeling independent of hypertension","volume":"164","author":"Dartsch","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2004.12.010","article-title":"RALES, EPHESUS and redox","volume":"93","author":"Funder","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","article-title":"Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats","volume":"47","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2014.12.011_bib27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1210\/jc.2013-2049","article-title":"Displacement of cortisol from human heart by acute administration of a mineralocorticoid receptor antagonist","volume":"99","author":"Iqbal","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cardfail.2014.12.011_bib28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.108.119966","article-title":"Reconsidering the roles of the mineralocorticoid receptor","volume":"53","author":"Funder","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2014.12.011_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism","volume":"57","author":"Seifarth","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cardfail.2014.12.011_bib30","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00125-008-0972-5","article-title":"Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles","volume":"51","author":"Swaminathan","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.cardfail.2014.12.011_bib31","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0735-1097(02)02382-3","article-title":"Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy","volume":"40","author":"Rousseau","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib32","doi-asserted-by":"crossref","DOI":"10.2459\/JCM.0000000000000156","article-title":"Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism","author":"Vergaro","year":"2014","journal-title":"J Cardiovasc Med (hagerstown)"},{"key":"10.1016\/j.cardfail.2014.12.011_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.07.019","article-title":"Non-genomic actions of aldosterone: from receptors and signals to membrane targets","volume":"350","author":"Dooley","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.steroids.2005.02.004","article-title":"Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system","volume":"70","author":"Mihailidou","year":"2005","journal-title":"Steroids"},{"key":"10.1016\/j.cardfail.2014.12.011_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/HYPERTENSIONAHA.110.157271","article-title":"Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism","volume":"56","author":"Amar","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2014.12.011_bib36","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.111.029892","article-title":"Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial","volume":"124","author":"Calhoun","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.12.011_bib37","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ijcard.2012.10.007","article-title":"The past, present and future of renin-angiotensin aldosterone system inhibition","volume":"167","author":"Mentz","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.amjcard.2011.03.034","article-title":"Prognostic value of plasma renin activity in heart failure","volume":"108","author":"Vergaro","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ijcard.2012.03.061","article-title":"Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease","volume":"167","author":"Poletti","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2014.12.011_bib40","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ehj.2003.10.030","article-title":"The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT","volume":"25","author":"Latini","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2014.12.011_bib41","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cardfail.2010.06.417","article-title":"Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT)","volume":"16","author":"Masson","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.12.011_bib42","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00125-004-1510-8","article-title":"Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes","volume":"47","author":"Davies","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.cardfail.2014.12.011_bib43","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ahj.2010.04.024","article-title":"Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1c levels in patients with chronic heart failure","volume":"160","author":"Yamaji","year":"2010","journal-title":"Am Heart J"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916414013645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916414013645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T14:24:11Z","timestamp":1537971851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916414013645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1071916414013645"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2014.12.011","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}